149 related articles for article (PubMed ID: 37484972)
1. Development and validation of a prognostic model incorporating tumor thrombus grading for nonmetastatic clear cell renal cell carcinoma with tumor thrombus: A multicohort study.
Qu L; Chen H; Chen Q; Ge S; Jiang A; Yu N; Zhou Y; Kunc M; Zhou Y; Feng X; Zhai W; Wu Z; He M; Li Y; Chen R; Han B; Zeng X; Fu Y; Ji C; Fan X; Zhang G; Zhao C; Jing T; Feng C; Zhao H; Sun D; Wang L; Tai S; Zhang C; Chen S; Liu Y; Wang H; Gao J; Gu Y; Miao H; Zhao T; Yi X; Tang C; Fu D; He H; Rao Q; Zhou W; Xu N; Wang G; Liang C; Liu Z; Xia D; Zu X; Chen M; Guo H; Qin W; Wang Z; Xue W; Shi B; Wang S; Zheng J; Chen C; Zapała Ł; Ge J; Wang L
MedComm (2020); 2023 Aug; 4(4):e300. PubMed ID: 37484972
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Wu Z; Chen H; Chen Q; Ge S; Yu N; Campi R; Gómez Rivas J; Autorino R; Rouprêt M; Psutka SP; Mehrazin R; Porpiglia F; Bensalah K; Black PC; Mir MC; Minervini A; Djaladat H; Margulis V; Bertolo R; Caliò A; Carbonara U; Amparore D; Borregales LD; Ciccarese C; Diana P; Erdem S; Marandino L; Marchioni M; Muselaers CHJ; Palumbo C; Pavan N; Pecoraro A; Roussel E; Warren H; Pandolfo SD; Chen R; Zhou W; Zhai W; He M; Li Y; Han B; Wan J; Zeng X; Yan J; Fu Y; Ji C; Fan X; Zhang G; Zhao C; Jing T; Wang A; Feng C; Zhao H; Sun D; Wang L; Tai S; Zhang C; Chen S; Liu Y; Xu Z; Wang H; Gao J; Wang F; Cheng J; Miao H; Rao Q; Wang J; Xu N; Wang G; Liang C; Liu Z; Xia D; Jiang J; Zu X; Chen M; Guo H; Qin W; Wang Z; Xue W; Shi B; Zhou X; Wang S; Zheng J; Ge J; Feng X; Li M; Chen C; Qu L; Wang L;
Eur Urol Oncol; 2024 Feb; 7(1):112-121. PubMed ID: 37468393
[TBL] [Abstract][Full Text] [Related]
3. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
Front Oncol; 2021; 11():646338. PubMed ID: 34249685
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus.
Gu Y; Fu Y; Pan X; Zhou Y; Ji C; Zhao T; Miao H; Lv H; Da J; Ge J; Wang L; Qu L; Ge S; Guo H; Zhou W
Front Oncol; 2023; 13():1117595. PubMed ID: 36776325
[TBL] [Abstract][Full Text] [Related]
5. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
Kaushik D; Linder BJ; Thompson RH; Eisenberg MS; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA
Urology; 2013 Jul; 82(1):136-41. PubMed ID: 23642851
[TBL] [Abstract][Full Text] [Related]
6. Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus.
Shi X; Pang Q; Nian X; Jiang A; Shi H; Liu W; Gan X; Gao Y; Yang Y; Ji J; Tan X; Xiao C; Zhang W
Sci Rep; 2023 Jun; 13(1):9778. PubMed ID: 37328520
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators for survival in renal cell carcinoma with venous thrombus and development of predictive nomograms.
Tian J; Zeng X; Guan W; Hu Z; Yang C
Transl Androl Urol; 2022 Oct; 11(10):1374-1388. PubMed ID: 36386258
[TBL] [Abstract][Full Text] [Related]
8. Construction of the prognostic model in non-metastatic renal cancer patients with venous tumor thrombus.
Zhu B; Yang Y; Huangfu Z; Zhang W; Jiang A; Wang L
Transl Androl Urol; 2023 Nov; 12(11):1645-1657. PubMed ID: 38106682
[TBL] [Abstract][Full Text] [Related]
9. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance and prognostic value of preoperative
Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M
Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma.
Zhang W; Liu W; Yang Y; Xiao C; Xiao Y; Tan X; Pang Q; Wu H; Hua M; Shi X
Front Oncol; 2023; 13():1102623. PubMed ID: 37035174
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of extent of venous tumor thrombus in patients with non-metastatic renal cell carcinoma: Results from a Canadian multi-institutional collaborative.
Shiff B; Breau RH; Mallick R; Pouliot F; So A; Tanguay S; Kapoor A; Lattouf JB; Lavallée L; Fairey A; Finelli A; Bhindi B; Kawakami J; Rendon R; Bansal RK
Urol Oncol; 2021 Dec; 39(12):836.e19-836.e27. PubMed ID: 34556430
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features of Papillary Renal Cell Carcinoma With Venous Tumor Thrombus: Case Series from a Large Chinese Center.
Liu Z; Ge L; Zhao X; Lu M; Aili A; Li Y; Zhu G; Hong P; Tian X; Wang S; Zhang H; Liu C; Ding Z; Zhang S; Ma L
Clin Med Insights Oncol; 2022; 16():11795549221092217. PubMed ID: 35465470
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center.
Chen Z; Yang F; Ge L; Qiu M; Liu Z; Liu C; Tian X; Zhang S; Ma L
BMC Cancer; 2021 Jul; 21(1):766. PubMed ID: 34215223
[TBL] [Abstract][Full Text] [Related]
16. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
[TBL] [Abstract][Full Text] [Related]
17. The extent of tumour fat invasion affects survival in patients with renal cell carcinoma and venous tumour thrombosis.
Bertini R; Roscigno M; Freschi M; Angiolilli D; Strada E; Petralia G; Sozzi F; Capitanio U; Cremonini A; Rigatti P
BJU Int; 2011 Sep; 108(6):820-4. PubMed ID: 21166759
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
Mager R; Daneshmand S; Evans CP; Palou J; Martínez-Salamanca JI; Master VA; McKiernan JM; Libertino JA; Haferkamp A; ; Haferkamp A; Capitanio U; Carballido JA; Chantada V; Chromecki T; Ciancio G; Daneshmand S; Evans CP; Gontero P; González J; Hohenfellner M; Huang WC; Koppie TM; Libertino JA; Espinós EL; Lorentz A; Martínez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; O'Malley P; Pahernik S; Palou J; Moreno JL; Pruthi RS; Faba OR; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Tilki D; Vázquez-Martul D; Donoso CV; Vergho D; Wallen EM; Zigeuner R
J Surg Oncol; 2016 Nov; 114(6):764-768. PubMed ID: 27562252
[TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.
Liu W; Fu Q; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Medicine (Baltimore); 2015 Nov; 94(45):e2004. PubMed ID: 26559293
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of
Zhu AH; Hou XY; Tian S; Zhang WF
Sci Rep; 2022 Jan; 12(1):587. PubMed ID: 35022440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
